Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1478 total)
-
Creator: NETEC
Subject: Emergency Management
Item Type: Guide
Date Last Updated: 2020-12-16
Description: This printable flyer infographic discusses the use of the HICS system with infectious disease outbreaks. Hospital incident command system (HICS) is a robust framework that helps hospitals prepare, mitigate, respond, and recover from threats, planned… -
Creator: NETEC
Subject: Emergency Management
Item Type: Webinar
Date Last Updated: 2020-12-16
Description: In this webinar, we will discuss the hesitancy surrounding the COVID-19 vaccine including the public fears related to the inconsistencies of risk communication, describe what resources are reliable and available to assist with interpretation of… -
Creator: NETEC
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-12-12
Description: This printable flyer infographic discusses Long-Term Care (LTC) and Assisted Living Facility Biosafety: Identify, Isolate and Inform. This asset has been updated. Go to the updated novel respiratory pathogen asset here.This asset has been updated. Go… -
Creator: NETEC
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-12-11
Description: This printable flyer infographic discusses safety and plans for CPR and Code Blue in a pandemic. CPR during the COVID-19 pandemic requires extra precautions. Follow the examples and tips shown here to keep everyone safe while resuscitating a patient. -
Creator: NETEC
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-12-10
Description: This printable flyer infographic discusses mAb for COVID-19. Monoclonal antibody therapeutics (mAb) are one of the first available medical countermeasure therapeutics for mild-to-moderate COVID-19 cases. This handout discusses what they are, the… -
Creator: Keech, Cheryl, Gary Albert, Iksung Cho, Andreana Robertson, Patricia Reed, Susan Neal, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Haixia Zhou, Gale Smith, Nita Patel, Matthew B. Frieman, Robert E. Haupt, James Logue, Marisa McGrath, Stuart…
Subject: Research
Item Type: Publication
Date Last Updated: 2020-12-10
Description: NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike glycoproteins and Matrix-M1 adjuvant. -
Creator: Huang, Edmund, and Stanley C. Jordan.
Subject: Research
Item Type: Publication
Date Last Updated: 2020-12-10
Description: Nearly 10 months after the identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the virus responsible for coronavirus disease 2019 (Covid-19), therapeutic options remain limited. -
Creator: Polack, Fernando P., Stephen J. Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L. Perez, Gonzalo Pérez Marc, Edson D. Moreira, Cristiano Zerbini, Ruth Bailey, Kena A. Swanson, Satrajit Roychoudhury, Kenneth Koury,…
Subject: Research
Item Type: Publication
Date Last Updated: 2020-12-10
Description: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently. -
Creator: NETEC
Subject: Emergency Management
Item Type: Guide
Date Last Updated: 2020-12-09
Description: This printable flyer infographic discusses the use of the HICS system with COVID-19. HICS helps hospitals prepare, mitigate, respond, and recover from an event that disrupts normal operations or threatens life, property, or the environment.This asset… -
Creator: the Oxford COVID Vaccine Trial Group
Subject: Research
Item Type: Publication
Date Last Updated: 2020-12-08
Description: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19…